Remote monitoring of cardiac implantable electrical devices in Europe: Quo vadis?

Europace

Volumn 17, Issue 5, 2015, Pages 674-676

  Boriani, Giuseppe ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIAC RESYNCHRONIZATION THERAPY DEVICE; HEALTH ECONOMICS; HEART FAILURE; HEART PACING; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; LEGAL ASPECT; NEW YORK HEART ASSOCIATION CLASS; PACEMAKER; PATIENT CARE; PRIORITY JOURNAL; REIMBURSEMENT; REMOTE SENSING; REVIEW; SURVIVAL; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVERSION; ECONOMICS; HEALTH CARE COST; HEART DISEASES; SIGNAL PROCESSING;

CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICES; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; HEALTH CARE COSTS; HEART DISEASES; HUMANS; INSURANCE, HEALTH, REIMBURSEMENT; REMOTE SENSING TECHNOLOGY; SIGNAL PROCESSING, COMPUTER-ASSISTED;

EID: 84929236776     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euv031     Document Type: Review

References (17)

1. BorianiG, Diemberger I, Martignani C, Biffi M, Valzania C, BertiniMet al. Telecardiology and remote monitoring of implanted electrical devices: the potential for fresh clinical care perspectives. J Gen Intern Med 2008;23(Suppl 1):73-7.
2. Varma N, Ricci RP. Telemedicine and cardiac implants: what is the benefit? Eur Heart J 2013;34:1885-95.
3. Landolina M, Perego GB, Lunati M, Curnis A, Guenzati G, Vicentini A et al. Remote monitoring reduces healthcare use and improves quality of care in heart failure patients with implantable defibrillators: the evolution of management strategies of heart failure patients with implantable defibrillators (EVOLVO) study. Circulation 2012;125:2985-92.
4. BorianiG,Da Costa A, Ricci RP, Quesada A, Favale S, Iacopino S et al. The MOnitoring Resynchronization dEvices and CARdiac patients (MORE-CARE) randomized controlled trial: phase 1 results on dynamics of early intervention with remote monitoring. J Med Internet Res 2013;15:e167.
5. Burri H, Sticherling C, Wright D, Makino K, Smala A, Tilden D. Cost-consequence analysis of daily continuous remote monitoring of implantable cardiac defibrillator and resynchronization devices in the UK. Europace 2013;15:1601-8.
6. Hindricks G, Elsner C, Piorkowski C, Taborsky M, Geller JC, Schumacher B et al. Quarterly vs. yearly clinical follow-up of remotely monitored recipients of prophylactic implantable cardioverter-defibrillators: results of the REFORM trial. Eur Heart J 2014;35:98-105.
7. Heidbuchel H, Hindricks G, Broadhurst P, Van Erven L, Fernandez-Lozano I, Rivero-Ayerza M et al. EuroEco (European Health Economic Trial on Home Monitoring in ICD Patients): a provider perspective in five European countries on costs and net financial impact of follow-up with or without remote monitoring. Eur Heart J 2015;36:158-69.
8. Hindricks G, Taborsky M, Glikson M, Heinrich U, Schumacher B, Katz A et al. Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial. Lancet 2014;384:583-90.
9. Hernández-Madrid A, Lewalter T, Proclemer A, Pison L, Lip GY, Blomstrom-Lundqvist C; Scientific Initiatives Committee, European Heart Rhythm Association. Remote monitoring of cardiac implantable electronic devices in Europe: results of the European Heart Rhythm Association survey. Europace 2014; 16:129-32.
10. BrignoleM, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt OA et al. 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Europace 2013;15:1070-118.
11. Arribas F, Auricchio A, Boriani G, Brugada J, Deharo JC, Hindriks G et al. Statistics on the use of cardiac electronic devices and electrophysiological procedures in 55 ESC countries: 2013 report from the European Heart Rhythm Association (EHRA). Europace 2014;16(Suppl 1):i1-78.
12. Mairesse GH, Braunschweig F, Klersy K, Cowie MR, Leyva F. Implementation and reimbursement of remote monitoring for cardiac implantable electronic devices in Europe: a survey from the Health Economics Committee of the European Heart Rhythm Association. Europace 2015;17:814-8.
13. Boriani G, Maniadakis N, Auricchio A, Müller-Riemenschneider F, Fattore G, Leyva F et al. Health technology assessment in interventional electrophysiology and device therapy: a position paper of the European Heart Rhythm Association. Eur Heart J 2013;34:1869-74.
14. Boriani G, Burri H, Mantovani LG, Maniadakis N, Leyva F, Kautzner J et al. Device therapy and hospital reimbursement practices across European countries: a heterogeneous scenario. Europace 2011;13(Suppl 2):ii59-65.
15. Chronaki CE, Vardas P. Remote monitoring costs, benefits, and reimbursement: a European perspective. Europace 2013;15(Suppl 1):i59-64.
16. Guédon-Moreau L, Lacroix D, Sadoul N, Clémenty J, Kouakam C, Hermida JS et al. ; ECOST trial Investigators. Costs of remote monitoring vs. ambulatory follow-ups of implanted cardioverter defibrillators in the randomized ECOST study. Europace 2014;16:1181-8.
17. Boriani G, Diemberger I, Mantovani V, Biffi M, Martignani C. Remote monitoring of patients with an implanted device and patients outcomes: the potential for "win-win" dynamics. J Cardiovasc Electrophysiol 2009;20:1252-4.